Brown Forman CORP

Brown-Forman Corporation's stockholders elected all director nominees, approved executive compensation, and ratified the selection of Ernst & Young LLP as auditors at the annual meeting.

Brown-Forman Corporation announced that President and CEO Lawson Whiting will retire upon the appointment of his successor, with the Board initiating a search process.

Brown-Forman announced its fiscal year 2026 results, with net sales down 1% to $3.9 billion, but provided a cautious outlook for FY27 expecting flat organic net sales amidst market volatility.

Brown-Forman Corporation and Pernod Ricard have terminated discussions regarding a potential business combination due to an inability to reach mutually agreeable terms.

Brown-Forman Corporation announced the appointment of Jim Peters as its new Executive Vice President and Chief Financial Officer, effective March 31, 2026.

Brown-Forman Corporation reported a 2% increase in third-quarter net sales and reaffirmed its full-year fiscal 2026 outlook despite a challenging operating environment.

Brown-Forman reported a 13% drop in diluted EPS to $0.83 for the first six months of fiscal 2026, with net sales down 4% to $1.96 billion, citing challenging macroeconomic conditions and strategic portfolio adjustments.

Brown-Forman reports a 3% decline in net sales and 13% drop in diluted EPS, while organic sales show modest growth amid challenging market conditions.

Brown-Forman's Q3 fiscal 2025 results reveal a sales decrease driven by divestitures and restructuring, though partially offset by growth in select brands and markets.

Brown-Forman's latest quarterly report reveals a decrease in net sales and operating income, influenced by divestitures and changing market dynamics, despite some positive trends in specific brands and regions.

Brown-Forman's first quarter of fiscal year 2025 saw a decrease in net sales and operating income, impacted by lower volumes, divestitures, and foreign exchange headwinds.

Brown-Forman's third-quarter results show a significant increase in operating income, but the company has revised its fiscal 2024 outlook due to slower than anticipated growth.

Brown-Forman Corporation reported a 1% decrease in net sales to $3.9 billion for fiscal 2026, alongside a 10% drop in operating income, reflecting challenging macroeconomic conditions and strategic portfolio adjustments.

Brown-Forman Corporation reported a 5% decrease in net sales and a 22% decline in operating income for fiscal year 2025, primarily due to divestitures and macroeconomic headwinds, while focusing on long-term strategic growth initiatives.

Brown-Forman Corporation's fiscal year 2024 results show a slight decrease in net sales but a significant increase in operating income, driven by strategic divestitures and cost management.

Michael Todman, a Director of Brown Forman Corp, received 6,476 shares of common stock on July 23, 2026.

Tracy L Skeans, a Director of Brown Forman Corp, received 6,476 shares of common stock on July 23, 2026.

Elizabeth A Smith, a Director of Brown Forman Corp, received 9,524 shares of common stock on July 23, 2026.

Jan Singer, a Director of Brown Forman Corp, received 6,476 shares of common stock on July 23, 2026.

Michael J Roney, a Director of Brown Forman Corp, received 6,476 shares of common stock on July 23, 2026.

Marshall Farrer, a Director of Brown Forman Corp, received 6,476 shares of common stock on July 23, 2026.

Brown-Forman Corporation's latest proxy statement reveals a challenging fiscal 2025 with declines in net sales, operating income, and diluted earnings per share, alongside a significant leadership transition and a company-wide restructuring plan.

Brown-Forman's 2024 Proxy Statement outlines proposals for stockholder voting, details director nominees, and provides an analysis of executive compensation.

Wolf Pen Branch, LP and its general partner, Wolf Pen Branch GP, LLC, have amended their Schedule 13D filing to reflect an increased beneficial ownership of Brown-Forman Corporation's Class A Common Stock, now representing 60.3% of the outstanding shares.

Vanguard Capital Management has reported a beneficial ownership of 16,213,828 shares, representing 5.58% of Brown-Forman Corp's common stock as of March 31, 2026.

The Vanguard Group has reported a 0% beneficial ownership in Brown-Forman Corp following an internal realignment, with subsidiaries now reporting separately.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 7.5% of Brown-Forman Corp's Class B Common Stock as of September 30, 2025.